Nirmatrelvir–ritonavir targeting viral persistence in post-COVID-19 condition (long COVID) in the USA (RECOVER-VITAL): a randomised, double-blind, placebo-controlled, phase 2 trial
Lindsey R. Baden, Lindsey R Baden, Nirav S Shah, Sean T H Liu et autres